| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $64,351,657 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DK139541 | Structural Mechanisms of Polycystic Kidney Disease Proteins | 000 | 2 | NIH | 4/15/2025 | $666,838 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R00HG011658 | Pan-disease characterization of DNA methylation dysregulation | 000 | 5 | NIH | 4/14/2025 | $224,099 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K01DK134800 | Development and Pilot Testing of an Adaptive Intervention to Prevent Weight Regain Following Weight Loss in Adults with Overweight and Obesity | 000 | 3 | NIH | 4/15/2025 | $153,526 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K23DA060310 | Behavior Change Components to Enhance Opioid Disposal After Surgery | 000 | 2 | NIH | 4/18/2025 | $198,720 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA279973 | PREVENT - Practice-based Approaches to Promote HPV Vaccination | 000 | 3 | NIH | 4/18/2025 | $567,343 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HL166513 | Mechanism of Eccentric Cardiomyocyte Hypertrophy Secondary to Mitral Regurgitation | 000 | 3 | NIH | 4/14/2025 | $534,740 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01EY034986 | Functional plasticity in retinal degenerative disease | 000 | 3 | NIH | 4/18/2025 | $385,000 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31AG082494 | Investigating the Lysosome and Plasma Membrane Systems in Protecting Cells Against Age-induced Amino Acid Toxicity | 000 | 3 | NIH | 4/17/2025 | $39,884 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21DA060453 | Genetics of Amphetamine Preference | 000 | 2 | NIH | 4/14/2025 | $191,521 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | U01DA041134 | 1/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT U UTAH | 001 | 11 | NIH | 3/12/2025 | $420,761 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | U01DA041134 | 1/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT U UTAH | 001 | 11 | NIH | 3/12/2025 | $2,035,408 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01GM019559 | Intracellular Signaling by Bacterial Chemoreceptors | 000 | 52 | NIH | 4/1/2025 | $577,181 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R37CA259156 | Using Natural Language Processing and Crowdsourcing to Monitor and Evaluate Public Information and Communication Disparities about Colon Cancer Screening | 000 | 5 | NIH | 4/15/2025 | $289,657 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F30CA260977 | T cell expressed miR-155 promotes antitumor immunity and immune checkpoint blockade responses in colon cancer through repression of Ship1 | 000 | 5 | NIH | 3/13/2025 | $56,974 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R33AT012329 | Specialized pro-resolving lipid mediators and treatment resistant depression | 001 | 3 | NIH | 4/1/2025 | $344,663 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R33AT012329 | Specialized pro-resolving lipid mediators and treatment resistant depression | 001 | 3 | NIH | 4/1/2025 | $40,284 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R33AT012329 | Specialized pro-resolving lipid mediators and treatment resistant depression | 001 | 3 | NIH | 4/1/2025 | $134,417 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K23DK132487 | The Serine Protease HTRA1 Antigen: A Gateway to Elucidating Membranous Nephropathy Pathogenesis and the Targeting of Antigen Epitopes | 000 | 3 | NIH | 4/1/2025 | $174,960 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HD104317 | Genetic and Environmental Regulation of Diaphragm Development and Congenital Diaphragmatic Hernias | 000 | 5 | NIH | 4/7/2025 | $475,998 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DK135968 | Beta-cell self-antigen recognition by diabetogenic CD8 T cells | 000 | 3 | NIH | 2/21/2025 | $346,500 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HL178117 | Assessing myocardial fibrosis with spin locked MRI | 000 | 1 | NIH | 3/10/2025 | $756,947 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DK133270 | Share plus: Continuous Glucose Monitoring with Data Sharing in Older Adults with T1D and Their Care Partners | 000 | 3 | NIH | 2/21/2025 | $277,200 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01EY036877 | The role of centriole linkage in retinal degeneration and hearing loss | 000 | 1 | NIH | 2/21/2025 | $462,430 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA282219 | Multilevel RCT of Rural Community Sun Safety for Young Children in Sports | 000 | 2 | NIH | 4/7/2025 | $509,398 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM140900 | Regulation of cell growth and proliferation | 001 | 5 | NIH | 4/8/2025 | $752,639 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA289731 | The combined role of ARID1A loss and estrogen signaling in endometrial cancer | 000 | 2 | NIH | 3/4/2025 | $380,042 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R37NS102978 | Noncanonical glutamate signaling in the origins of the migraine attack | 000 | 7 | NIH | 3/4/2025 | $605,840 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | UG1CA233178 | Huntsman Cancer Institute/ University of Utah Network Lead Academic Participating Site Application | 002 | 6 | NIH | 3/10/2025 | $301,967 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01MH104603 | Deciphering gene-environment interactions in pathological reactive aggression | 000 | 9 | NIH | 3/4/2025 | $626,434 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | UG3CA287109 | Population Health Management Approaches to Increase Lung Cancer Screening in Community Health Centers | 000 | 2 | NIH | 4/14/2025 | $575,185 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | UG1DA049444 | Greater Intermountain Node | 001 | 6 | NIH | 2/21/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R37CA247994 | Mitochondrial lateral transfer during metastasis | 001 | 5 | NIH | 3/21/2025 | $313,959 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA266302 | Optimization of a personalized skin cancer risk intervention for at-risk young adults | 000 | 3 | NIH | 4/11/2025 | $479,510 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM150766 | Integrated mass spectrometry-based chemoproteomic and genomic technologies for studying dynamic kinase interactomes | 000 | 3 | NIH | 4/11/2025 | $385,000 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F30DA063315 | Understanding pain embodiment and opioid misuse risk in chronic pain using neuroimaging | 000 | 1 | NIH | 4/11/2025 | $39,983 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R33TW011636 | Rwanda 912: an mHealth Application to Improve Quality of Trauma and Emergency Care in Kigali, Rwanda | 000 | 5 | NIH | 4/12/2025 | $253,338 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DK139317 | Discovery and design of novel insulin evologs from venomous marine cone snails | 000 | 2 | NIH | 2/25/2025 | $351,923 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21AI185994 | Elucidating influenza-induced protection of malaria-associated respiratory distress syndrome in mice | 000 | 1 | NIH | 2/24/2025 | $224,070 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01NS126652 | Exploring p53-mediated ferroptosis to treat IDH1-mutant glioma | 000 | 3 | NIH | 4/4/2025 | $346,500 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K23MH135225 | Examining Mechanisms of Change in Adolescent Self-Inflicted Injury | 001 | 2 | NIH | 4/4/2025 | $199,481 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HL162856 | Autonomic Dysfunction in Patients with HFpEF | 000 | 3 | NIH | 4/10/2025 | $615,718 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AA030881 | Transcriptional Regulation of Alcohol Sensitivity and Tolerance | 000 | 3 | NIH | 4/24/2025 | $528,813 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01MH134284 | Building Resources for the Diversification of Genetic Data on Suicide Death | 000 | 2 | NIH | 4/23/2025 | $306,806 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HG012252 | New algorithms and tools for large-scale genomic analyses | 001 | 4 | NIH | 4/24/2025 | $64,242 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HD107077 | Economic security policy and birth outcomes among socio-economically disadvantaged women | 001 | 3 | NIH | 4/24/2025 | $32,178 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | T32HD007491 | Developmental Biology Training Program | 000 | 28 | NIH | 4/24/2025 | $462,452 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HL170007 | Cardiovascular and neuromuscular issues in chronic pain | 000 | 2 | NIH | 4/24/2025 | $686,302 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HG012286 | Calypso: a web software system supporting team-based, longitudinal genomic diagnostic care | 001 | 4 | NIH | 4/24/2025 | $89,298 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R37CA276044 | Liquid Biopsy in Myeloma to Inform Outcome and Treatment Decisions | 003 | 3 | NIH | 4/23/2025 | $154,615 |
|
